Results from an early safety study of Moderna Inc’s coronavirus vaccine candidate in older adults showed that it produced virus-neutralising antibodies at levels similar to those seen in younger adult...
সম্পূর্ণ আর্টিকেলটি পড়ুন
We use cookies to ensure you get the best experience on our website.